Mechanistic Insights into Radiation Resistance in Colorectal Cancer: Gene Exploration Study

Area of Science:

• Oncology
• Molecular Biology
• Radiotherapy Research

Background:

• Radiotherapy is a primary treatment for colorectal cancer (CRC).
• Therapeutic success is limited by intrinsic and acquired resistance in CRC cells.
• Identifying molecular targets to overcome resistance is crucial for improving treatment outcomes.

Purpose of the Study:

• To investigate the roles of BAMBI, GADD34, NFKBIA, and NFKBID in colorectal cancer progression and radiation resistance.
• To evaluate the impact of silencing these genes on CRC cell behavior and sensitivity to radiotherapy.
• To explore potential therapeutic targets for overcoming radioresistance in CRC.

Main Methods:

• Utilized small interfering RNA (siRNA) technology for gene silencing in SW480 and HCT116 colorectal cancer cell lines.
• Assessed the effects of gene knockdown on cell proliferation, migration, and invasion.
• Quantified changes in apoptosis and cell viability to determine radiation sensitivity.

Main Results:

• Gene silencing of BAMBI, GADD34, NFKBIA, and NFKBID significantly inhibited CRC cell proliferation, migration, and invasion.
• siRNA-mediated knockdown markedly enhanced radiation sensitivity.
• Knockdown led to increased apoptosis and reduced cell viability post-irradiation compared to control groups.

Conclusions:

• BAMBI, GADD34, NFKBIA, and NFKBID are critical regulators of colorectal cancer progression and radiation resistance.
• Targeting these genes represents a promising strategy to enhance radiotherapy efficacy.
• Findings provide a mechanistic basis for developing personalized radiotherapy approaches based on molecular profiling.